In conclusion, in patients with hematological malignancies who underwent cell therapies, the ability to acutely upregulate IFN-γ and IP-10/CXCL10 at the priming vaccination and IFN-γ, IL-15, IL-7 and IL-10 upon booster vaccination were predictive of successful Ab development. This evidence concerns the gene IL10 and hematologic disorder.